Moreover, Cxcr3-expressing Th1-like CD4+ T cells have been shown to be induced as nanoparticles that target tumor-draining lymph nodes [44], which is consistent with our nanomedicine that targets the tumor niche. Here, CXCR3 is linked to neoplasm.